Actively Recruiting
Resistance Training and Corticospinal Excitability in Multiple Sclerosis
Led by University of Aarhus · Updated on 2024-12-11
54
Participants Needed
2
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
University of Aarhus
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of the present study is to investigate effects of progressive resistance training on central nervous system functioning (corticospinal excitability (CSE)) and walking capacity in persons with multiple sclerosis (pwMS). A total of 54 pwMS will be enrolled and randomized into 1 of 3 groups: high dose resistant training (RT), low dose RT, and waitlist control.
CONDITIONS
Official Title
Resistance Training and Corticospinal Excitability in Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥ 18 years
- MS diagnosis according to the McDonald diagnostic criteria
- Shows impairments in walking capacity
- Ability to self transport to test and exercise
You will not qualify if you...
- Pregnancy
- Neurological or other comorbidities that affects the nervous system
- Relapse within the past 2 months
- Pacemaker or metallic implants
- Hypertension (medically unregulated)
- Participation in structured RT over the past 3 months (≥ 2 sessions/week).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Department of Public Health
Aarhus, Central Jutland, Denmark, 8000
Actively Recruiting
2
Department of Nutrition, Exercise and Sports, University of Copenhagen
Copenhagen, Copenhagen N, Denmark, 2200
Actively Recruiting
Research Team
L
Lars Hvid, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here